A CRA expert provided an opinion on damages in patent litigation concerning intellectual property used in a vaccine for porcine viruses. CRA’s reasonable royalty opinion, on behalf of the defendant animal health company, was based in large part upon the payment terms of an existing license previously granted by the plaintiff.
CRA consultants recognized among leading IP professionals in the 2025 IAM Strategy 300
Daniel McGavock, Robert Goldman, and Dr. Richard Razgaitis were recognized as leading IP strategists by Intellectual Asset Management (IAM) in the latest...